Cardiovascular disease prevention in primary care

被引:7
|
作者
Chauhan, Umesh [1 ]
机构
[1] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England
关键词
communication; CVD risk assessment; management and surveillance;
D O I
10.1093/bmb/ldm002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the publication of the National Service Framework for coronary heart disease, there has been a move towards primary disease prevention with a greater focus on an individual's absolute risk. Meta-analysis and systematic reviews of the evidence for primary prevention are incomplete and the current guidelines and policy have led to considerable confusion in clinical practice. There is an increased use of risk assessment tools but no effective method of reviewing current activity with the limited integration into the existing Quality Outcome Framework. There is an inadequate evidence for some of the risk factors used to identify individuals at risk, the risk calculators used to quantify the degree of risk and the methods of communicating risk to patients are largely unproven or completely missing. There is a need for a co-ordinated vascular disease prevention programme which can be applied at the individual and at the population level but is also amenable to evaluation.
引用
收藏
页码:65 / 79
页数:15
相关论文
共 50 条
  • [41] Statins for the primary prevention of cardiovascular disease
    Ebrahim, Shah
    Taylor, Fiona C.
    Brindle, Peter
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [42] PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE
    MCEWAN, SR
    MCEWEN, J
    SCOTTISH MEDICAL JOURNAL, 1989, 34 (01) : 387 - 388
  • [43] Statins in the primary prevention of cardiovascular disease
    Željko Reiner
    Nature Reviews Cardiology, 2013, 10 : 453 - 464
  • [44] Allicor in the primary prevention of cardiovascular disease
    Pryanishnikov, V
    Sobenin, I
    Kunnova, L
    Rabinovich, E
    Orekhov, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 118 - 118
  • [45] Statins in the primary prevention of cardiovascular disease
    Reiner, Zeljko
    NATURE REVIEWS CARDIOLOGY, 2013, 10 (08) : 453 - 464
  • [46] Statins for the primary prevention of cardiovascular disease
    Taylor, Fiona
    Ward, Kirsten
    Moore, Theresa H. M.
    Burke, Margaret
    Smith, George Davey
    Casas, Juan-Pablo
    Ebrahim, Shah
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (01):
  • [47] PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE
    GARRETT, RE
    JOURNAL OF FAMILY PRACTICE, 1986, 22 (03): : 222 - &
  • [48] Aspirin for primary prevention of cardiovascular disease
    Nansseu J.R.N.
    Noubiap J.J.N.
    Thrombosis Journal, 13 (1)
  • [49] Statins in primary prevention of cardiovascular disease
    Adham, S.
    Miranda, S.
    Doucet, J.
    Levesque, H.
    Benhamou, Y.
    REVUE DE MEDECINE INTERNE, 2018, 39 (01): : 42 - 49
  • [50] Primary prevention of cardiovascular disease in women
    Gray, M. P.
    Vogel, B.
    Mehran, R.
    Leopold, J. A.
    Figtree, G. A.
    CLIMACTERIC, 2024, 27 (01) : 104 - 112